Menu
Search
|

Menu

Close
X

STRATA Skin Sciences Inc SSKN.OQ (NASDAQ Stock Exchange Capital Market)

1.83 USD
-0.05 (-2.66%)
As of 1:30 AM IST
chart
Previous Close 1.88
Open 1.82
Volume 17,547
3m Avg Volume 28,709
Today’s High 1.89
Today’s Low 1.82
52 Week High 2.80
52 Week Low 1.06
Shares Outstanding (mil) 2.48
Market Capitalization (mil) 4.36
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 1 analysts

KEY STATS

Revenue (mm, USD)
FY18
6
FY17
31
FY16
32
FY15
18
EPS (USD)
FY18
-0.509
FY17
-1.348
FY16
-1.598
FY15
-17.231
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.76
Price to Sales (TTM)
vs sector
0.13
5.73
Price to Book (MRQ)
vs sector
0.38
5.45
Price to Cash Flow (TTM)
vs sector
4.17
23.29
Total Debt to Equity (MRQ)
vs sector
216.14
16.72
LT Debt to Equity (MRQ)
vs sector
185.43
12.39
Return on Investment (TTM)
vs sector
-15.67
14.61
Return on Equity (TTM)
vs sector
-40.41
16.34

EXECUTIVE LEADERSHIP

LuAnn Via
Chairman of the Board, Since 2017
Salary: --
Bonus: --
Frank McCaney
President, Director, Since 2018
Salary: --
Bonus: --
Dolev Rafaeli
Interim Chief Executive Officer, Since 2018
Salary: --
Bonus: --
Matthew Hill
Chief Financial Officer, Since 2018
Salary: --
Bonus: --
James Coyne
Director, Since 2017
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

100 Lakeside Dr Ste 100
HORSHAM   PA   19044-2352

Phone: +1215.6193200

STRATA Skin Sciences, Inc., formerly MELA Sciences, Inc., is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging. The XTRAC and VTRAC products are the devices used for the treatment of psoriasis, vitiligo and other skin disorders. The XTRAC system delivers targeted ultraviolet light to affected areas of skin, leading to psoriasis clearing and vitiligo repigmentation, following a series of treatments. The Company's technology includes XTRAC Excimer Laser, VTRAC Lamp and MelaFind. MelaFind is a non-invasive, point-of-care instrument to aid dermatologists in their decision to biopsy suspicious pigmented lesions, such as melanoma. The Company has approximately two distribution channels for phototherapy treatment equipment.

SPONSORED STORIES